Author

Inge Marie Svane

Herlev HospitalORCID 0000-0002-9451-6037Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:mouse· 1

Frequent Co-Authors

Anders Handrup KvernelandiD· 2 shared Amalie Kai BentzeniD· 1 shared André RosaiD· 1 shared Andrea Marion MarquardiD· 1 shared Anne-Mette BjerregaardiD· 1 shared Annie BorchiD· 1 shared Carlos‐Filipe PereiraiD· 1 shared Charlotte VeseriD· 1 shared

Activity by Year

2024-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Anders Handrup KvernelandORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Checkpoint receptors in circulating γδ T cells can discern the outcome of cancer immunotherapy

Elisa Catafal Tardos, Lola Dachicourt, María Virginia Baglioni, Marcelo Gregorio Filho Fares da Silva, Davide Secci, Marco Donia, Anders Handrup Kverneland, Inge Marie Svane, Vasileios Bekiaris

This study examines how checkpoint receptors in circulating γδ T cells correlate with cancer immunotherapy outcomes, identifying potential prognostic markers and therapeutic targets.

EMBO Molecular Medicine · Nov 27, 2025Peer-reviewedImmunology

A cancer immunotherapy modality based on dendritic cell reprogramming in vivo

Ervin Ascic, Malavika Sreekumar Nair, André Rosa, Ilia Kurochkin, Olga Zimmermannová, Nadezhda Rotankova, Charlotte Veser, Tommaso Ballocci, Tiffany Schärer, Xiaoli Huang, Emilie Renaud, Marta Velasco Santiago, Özcan Met, David Askmyr, Malin Lindstedt, , Carlos‐Filipe Pereira

This study reprograms tumor cells in vivo to function as dendritic cells, leading to tumor regression and long-term immunity in mouse models.

Science · Aug 1, 2024Peer-reviewedImmunology

Fully automated workflow for integrated sample digestion and Evotip loading enabling high-throughput clinical proteomics

Anders Handrup Kverneland, Florian Harking, Joel Mario Vej-Nielsen, Magnus Huusfeldt, Dorte B. Bekker‐Jensen, Inge Marie Svane, Nicolai Bache, Jesper Velgaard Olsen

The paper presents an automated workflow for proteome and phosphoproteome sample preparation, enabling high-throughput clinical proteomics analysis of metastatic melanoma patients' plasma.

Molecular & Cellular Proteomics · May 20, 2024Peer-reviewedMolecular Biology

Identification and characterization of neoantigen-reactive CD8+ T cells following checkpoint blockade therapy in a pan-cancer setting

Keith Henry Moss, Ulla Kring Hansen, Vinicius Araújo Barbosa de Lima, Annie Borch, Esteban Sanchez Marquez, Anne-Mette Bjerregaard, Østrup Olga, Amalie Kai Bentzen, Andrea Marion Marquard, Mohammed kadivar, Inge Marie Svane, Ulrik Lassen, Sine Reker Hadrup

The paper detects neoantigen-reactive CD8+ T cells in tumor biopsies and peripheral blood post-checkpoint blockade therapy and identifies peptide hydrophobicity and treatment-induced phenotypes as factors influencing their response.

bioRxiv · Mar 17, 2024 · PreprintImmunology